CN102091165A - Traditional Chinese medicine for treating chronic hepatitis - Google Patents

Traditional Chinese medicine for treating chronic hepatitis Download PDF

Info

Publication number
CN102091165A
CN102091165A CN2010105659252A CN201010565925A CN102091165A CN 102091165 A CN102091165 A CN 102091165A CN 2010105659252 A CN2010105659252 A CN 2010105659252A CN 201010565925 A CN201010565925 A CN 201010565925A CN 102091165 A CN102091165 A CN 102091165A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
chronic hepatitis
effect
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105659252A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2010105659252A priority Critical patent/CN102091165A/en
Publication of CN102091165A publication Critical patent/CN102091165A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating chronic hepatitis, belonging to the field of traditional Chinese medicines for treating the digestive system disease. The traditional Chinese medicine has the advantages of good effect and rapid effect taking capacity. The traditional Chinese medicine is prepared from the raw materials, such as cordate houttuynia, white atractylodes rhizome, glossy ganoderma, pseudo-ginseng, red-rooted salvia root, capillary artemisia, pericarpium citri reticulatae viride and the like. The traditional Chinese medicine has the functions of strengthening the body resistance, tonifying qi and nourishing blood, clearing heat and detoxicating, promoting blood circulation and removing blood stasis, and relieving pain, and has the advantages of remarkable effect, accurate treatment effect and rapid effect taking capacity.

Description

A kind of Chinese medicine for the treatment of chronic hepatitis
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug, liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function decline, hepatic fibrosis etc., life quality descends greatly, and I and family members are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of chronic hepatitis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Houttuyniae 6-18 part Rhizoma Atractylodis Macrocephalae 5-15 part Ganoderma 6-18 part
Radix Notoginseng 3-9 part Radix Salviae Miltiorrhizae 6-18 part Herba Artemisiae Scopariae 6-18 part
Pericarpium Citri Reticulatae Viride 5-15 part
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hour, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with 1: 20 hot water (95 ℃) lixiviate → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think that the main diseases of chronic hepatitis B is because of being the heresy of epidemic disease poison at research.Be patient's hypoimmunity, cause viral infection, outbreak inflammation, state of an illness delay, obstinate.Though under present technical conditions, still virus can't be driven away fully externally, remove totally, we can suppress it by enhancing human body immunity power, and the control virus replication reduces viral load, and this is the key of treatment primary disease.So we attach most importance to Fuzheng Jiedu, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling is taken good care of the liver spleen, Qinghua hot and humid ecchymosis.The value of maximum of the present invention just is: it has captured difficult two " difficult problems " that heal of delay in the chronic hepatitis treatment---and the one, " dull pain in liver " that is difficult to overcome significantly alleviated even disappeared, and the 2nd, insoluble " hepatic fibrosis reverse " realizes substantially or fully.This is that doctor and patient call expectation hope for many years again and again.Ganoderma, Rhizoma Atractylodis Macrocephalae the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, the pivotal role of outstanding immunity, the easing the affected liver nourishing the liver, the spleen invigorating activating the spleen, enhancing human body immunity power, " opposing " interaction energy of immunity effectively resists hepatitis B virus duplicating in vivo, reduces its quantity; Radix Salviae Miltiorrhizae, Radix Notoginseng passage, nourishing blood, promoting blood circulation, removing blood stasis and relieving pain is enriched blood with nourishing the liver and kidney, removes the stagnant heat of blood part, and " reparation " effect of immunity can be repaired impaired hepatic tissue and liver function; Be aided with the soothing the liver dispelling the stagnated QI of Pericarpium Citri Reticulatae Viride, rush down pain relieving clearly, to separate dull pain in liver; The Herba Houttuyniae heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, inducing diuresis for treating stranguria syndrome; The soothing the liver heat clearing away of Herba Artemisiae Scopariae, eliminating damp, detoxifying is removed the damp and hot evil poison of bridle for a long time.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and heat-clearing and toxic substances removing, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Herba Houttuyniae 70 gram Rhizoma Atractylodis Macrocephalaes 60 kairine sesames 70 grams
Radix Notoginseng 30 gram Radix Salviae Miltiorrhizaes 70 gram Herba Artemisiae Scopariaes 70 grams
Pericarpium Citri Reticulatae Viride 60 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Herba Houttuyniae, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride are extracted, make extract fine powder 80 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 392 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Herba Houttuyniae 120 gram Rhizoma Atractylodis Macrocephalaes 90 kairine sesames 120 grams
Radix Notoginseng 50 gram Radix Salviae Miltiorrhizaes 120 gram Herba Artemisiae Scopariaes 120 grams
Pericarpium Citri Reticulatae Viride 90 grams
By above-mentioned same method, make 650 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Herba Houttuyniae 180 gram Rhizoma Atractylodis Macrocephalaes 150 kairine sesames 180 grams
Radix Notoginseng 80 gram Radix Salviae Miltiorrhizaes 180 gram Herba Artemisiae Scopariaes 180 grams
Pericarpium Citri Reticulatae Viride 150 grams
By above-mentioned same method, make 1014 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
9 parts of 6 portions of Ganodermas of 9 parts of Rhizoma Atractylodis Macrocephalaes of Herba Houttuyniae
9 parts of 9 portions of Herba Artemisiae Scopariaes of 4 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng
6 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
16 parts of 12 portions of Ganodermas of 16 parts of Rhizoma Atractylodis Macrocephalaes of Herba Houttuyniae
16 parts of 16 portions of Herba Artemisiae Scopariaes of 7 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng
12 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 8 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood total bilirubin etc. are unusual.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 4 examples do not have other serious disease, and the age is 51 years old-77 years old, 63.6 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are obviously alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is obviously alleviated; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.

Claims (1)

1. Chinese medicine for the treatment of chronic hepatitis, it is characterized in that: it is to make with the component of following weight ratio: Herba Houttuyniae 6-18 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Ganoderma 6-18 part, Radix Notoginseng 3-9 part, Radix Salviae Miltiorrhizae 6-18 part, Herba Artemisiae Scopariae 6-18 part, Pericarpium Citri Reticulatae Viride 5-15 part.
CN2010105659252A 2010-11-25 2010-11-25 Traditional Chinese medicine for treating chronic hepatitis Pending CN102091165A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105659252A CN102091165A (en) 2010-11-25 2010-11-25 Traditional Chinese medicine for treating chronic hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105659252A CN102091165A (en) 2010-11-25 2010-11-25 Traditional Chinese medicine for treating chronic hepatitis

Publications (1)

Publication Number Publication Date
CN102091165A true CN102091165A (en) 2011-06-15

Family

ID=44124543

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105659252A Pending CN102091165A (en) 2010-11-25 2010-11-25 Traditional Chinese medicine for treating chronic hepatitis

Country Status (1)

Country Link
CN (1) CN102091165A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389480A (en) * 2011-09-16 2012-03-28 北京绿源求证科技发展有限责任公司 Chinese medicament for treating hepatitis
CN102631444A (en) * 2012-03-31 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis
CN102670872A (en) * 2012-06-07 2012-09-19 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843694A (en) * 2009-09-25 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating chronic hepatitis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843694A (en) * 2009-09-25 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating chronic hepatitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王维伟 陈建杰: "陈建杰善用苍白二术从湿论治慢乙肝经验", 《辽宁中医杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389480A (en) * 2011-09-16 2012-03-28 北京绿源求证科技发展有限责任公司 Chinese medicament for treating hepatitis
CN102631444A (en) * 2012-03-31 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis
CN102670872A (en) * 2012-06-07 2012-09-19 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis

Similar Documents

Publication Publication Date Title
CN102389480A (en) Chinese medicament for treating hepatitis
CN102379989A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101843694A (en) Chinese medicament for treating chronic hepatitis
CN101953924A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102327358A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102379947A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102091165A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101953925A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102172375A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101991685A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102389479A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102068533A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101979023A (en) Chinese medicine for curing chronic hepatitis
CN102068529A (en) Traditional Chinese medicine for treatment of prostatic hyperplasia
CN101972349A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102379994A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102138995A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101972330A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102048873A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101979006A (en) Chinese medicament for treating chronic hepatitis
CN102389542A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN102114109A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843756B (en) Chinese medicament for treating chronic nephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110615